May 29, 2019

Heather Schneider, Michael Johnson and Tara Thieme spoke on the second webinar in a four-part series co-hosted by Willkie and Taylor Wessing covering various aspects of biosimilars litigation, market access and regulation.

Session 2 of this series focused on key factors decision makers need to be aware of when considering currently pending legislation, including:

  • Key provisions of proposed legislation
  • European perspectives and approaches to similar issues

To listen to a recording of the event, please click here.

Related Practice Areas